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Editors: Anton N. Sidawy and Bruce A. PerlerResults of the randomized, placebo-controlled clopidogrel and
acetylsalicylic acid in bypass surgery for peripheral arterial disease
(CASPAR) trial
Jill J.F. Belch, John Dormandy
Objective: Dual antiplatelet therapy with clopidogrel plus acetylsalicylic
acid (ASA) is superior to ASA alone in patients with acute coronary syndromes
and in those undergoing percutaneous coronary intervention. We sought to
determine whether clopidogrel plus ASA conferred benefit on limb outcomes
over ASA alone in patients undergoing below-knee bypass grafting.
Methods: Patients undergoing unilateral, below-knee bypass graft for
atherosclerotic peripheral arterial disease (PAD) were enrolled 2 to 4 days
after surgery and were randomly assigned to clopidogrel 75 mg/day plus
ASA 75 to 100 mg/day or placebo plus ASA 75 to 100 mg/day for 6 to 24
months. The primary efficacy endpoint was a composite of index-graft occlu-
sion or revascularization, above-ankle amputation of the affected limb, or
death. The primary safety endpoint was severe bleeding (Global Utilization
of Streptokinase and Tissue plasminogen activator for Occluded coronary
arteries [GUSTO] classification).
Results: In the overall population, the primary endpoint occurred in 149 of
425 patients in the clopidogrel group vs 151 of 426 patients in the placebo
(plus ASA) group (hazard ratio [HR], 0.98; 95% confidence interval [CI],
0.78-1.23). In a prespecified subgroup analysis, the primary endpoint was
significantly reduced by clopidogrel in prosthetic graft patients (HR, 0.65;
95% CI, 0.45-0.95; P = .025) but not in venous graft patients (HR, 1.25; 95%
CI, 0.94-1.67, not significant [NS]). A significant statistical interaction
between treatment effect and graft type was observed (Pinteraction = .008).
Although total bleeds were more frequent with clopidogrel, there was no
significant difference between the rates of severe bleeding in the clopido-
grel and placebo (plus ASA) groups (2.1% vs 1.2%).
Conclusion: The combination of clopidogrel plus ASA did not improve limb or
systemic outcomes in the overall population of PAD patients requiring below-
knee bypass grafting. Subgroup analysis suggests that clopidogrel plus ASA
confers benefit in patients receiving prosthetic grafts without significantly
increasing major bleeding risk.Quality of life in patients with no-option critical limb ischemia underlines
the need for new effective treatment
Ralf W. Sprengers, Martin Teraa, Frans L. Moll, G. Ardine de Wit, Yolanda van
der Graaf, Marianne C. Verhaar
Objective: To provide a solid baseline reference for quality of life (QoL) in
patients with no-option critical limb ischemia (CLI). CLI is associated with
surgery, endovascular interventions, hospitalization, and a poor prognosis.
An increasing number of clinical trials are, therefore, investigating new
treatment strategies (eg, therapeutic neovascularization) in patients with* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00538-1CLI. QoL serves as an important secondary endpoint in many of these trials,
but solid reference QoL data for patients with no-option CLI are lacking.
Methods: The Medical Outcomes Study Short Form 36 (SF-36) and the Euro-
Qol-5D (EQ-5D) questionnaires were used to obtain baseline QoL scores from
47 patients with no-option CLI participating in a therapeutic neovasculariza-
tion trial. To allow for easy comparability, a norm-based scoring (NBS)
method was used to report the results of the SF-36. Scores of patients with
CLI were furthermore compared with scores of patients with milder forms of
peripheral arterial disease (PAD) and with patients with cardiovascular risk
factors only. Determinants of QoL in patients with PAD were identified using
multiple linear regression methods.
Results: Patients with no-option CLI reported QoL scores below the general
population mean on every health dimension of the SF-36. Physical func-
tioning, role physical functioning, and bodily pain were affected most inten-
sively. These poor physical QoL scores were further underlined when
compared with other patients with milder forms of PAD or patients with
cardiovascular risk factors only. Patients with CLI scored poorly on the
pain/discomfort and the usual activities domain of the EQ-5D. Diabetes,
female gender, body mass index, and the ankle-brachial index at rest were
significant determinants of the QoL in PAD on multivariate analysis.
Conclusion: The QoL data of patients with no-option CLI using NBS methods
for the SF-36 provide a baseline reference for ongoing clinical trials on new
treatment strategies. Our data stress the need for new revascularization
therapies in patients with no-option CLI.Open and endovascular repair of type B aortic dissection in the
Nationwide Inpatient Sample
Teviah Sachs, Frank Pomposelli, Robert Hagberg, Allen Hamdan, Mark Wyers,
Kristina Giles, Marc Schermerhorn
Background: The use of stent grafts and mortality of stent graft repair of
type B thoracic aortic dissection (TBAD) is not well defined. We sought to
determine national estimates for the use and mortality of thoracic endovas-
cular aortic repair (TEVAR) for TBAD in the United States.
Methods: Records of the Nationwide Inpatient Sample (NIS) database
between 2005 and 2007 were examined. International Classification of
Diseases, 9th edition (ICD-9) diagnosis codes were used to select patients
who underwent open or TEVAR with a stent graft for a diagnosis of thoracic
aortic dissection or thoracoabdominal aortic dissection. We excluded
patients with a diagnosis code for aortic aneurysm and those with procedure
codes for cardioplegia or for operations on heart vessels or valves, which
were considered type A dissections (TAAD). The remaining patients were
considered as TBAD. We compared demographics and comorbidities, as well
as adjusted complications and mortality rates, between patients undergoing
TEVAR vs open repair.
Results: We identified an estimated 10,466 repairs for dissection of the
thoracic or thoracoabdominal aorta (open, 8659; TEVAR, 1818). Of these,
464 had a diagnosis of aortic aneurysm, and 5002 patients were considered
TAAD. Of nonaneurysmal dissections, 5000 repairs were considered TBAD
(open, 3619; TEVAR, 1381). The endovascular patients were older and had
544 Abstractsgreater comorbidities, although only cardiac disease, renal failure, hyper-
tension, and peripheral vascular disease were statistically significant. In-
hospital mortality was 19% for open repair vs 10.6% for TEVAR (odds ratio
[OR], 2.24; 95% confidence interval [CI], 1.36-3.67; P < .01). In-hospital
mortality was significantly higher with open repairs coded as emergent
admissions (20.1% vs 13.1%; P = .03), but did not reach statistical significance
for elective admissions (12.3% vs 4.8%; P = .09). Cardiac complications (12.4%
vs 4.9%, P < .01), respiratory complications (7.7% vs 4.3%, P = .02), genito-
urinary complications (9.0% vs 2.5%, P < .01), hemorrhage (14.0% vs 2.8%,
P < .01), and acute renal failure (32.1% vs 17.2%, P < .01) were more
frequent in the open repair group. Median length of stay was greater in
the open repair group (10.7 vs 8.3 days, P < .01).
Conclusion: For patients with a diagnosis of TBAD who undergo repair, the
endovascular approach is being used for older patients with greater comor-
bidities, yet has reduced morbidity and in-hospital mortality. The use of en-
dovascular stent graft repair for type B thoracic aortic dissection merits
further longitudinal analysis.Endovascular repair of thoracic aortic traumatic transections is a safe
method in patients with complicated injuries
Saum A. Rahimi, R. Clement Darling III, Manish Mehta, Sean P. Roddy, John
B. Taggert, Yaron Sternbach
Purpose: Historically thoracic aortic rupture secondary to trauma was
treated with cardiopulmonary bypass and open surgery. With the advent
of endovascular grafting, physicians have the ability to reconstruct the
thoracic aortic transection using a less invasive technique. In this study,
we examine our experience with stent graft repair of thoracic transections
secondary to trauma.
Methods: The medical records of patients treated at a level I trauma center
from 2005 to 2008 were reviewed. Those patients who had an aortic transec-
tion treated with an endograft were identified and evaluated for in-hospital
mortality and morbidity and concurrent injuries. Demographics, procedural
details, and outcomes were analyzed.
Results: Over a 3-year period, 18 thoracic aortic transections secondary to
trauma were identified in patients with a mean age of 43 (range, 16-80).
Primary technical success was 100%. None of the patients required explant
or open repair during this time period. In-hospital mortality was 2 of 18
(11%); all patients had multiple trauma including long bone fractures. The
subclavian artery origin was covered by the stent graft in 9 of the 18
patients. The mean estimated blood loss per procedure was 222 cc. No
patient in this series had postoperative paraplegia. Follow-up ranged from
1 to 50 months with an average of 13 months. There have been no late
explantation or device failures identified.
Conclusion: Endovascular repair of traumatic thoracic aortic transections
can be performed safely with a relatively low mortality and morbidity and
should be the procedure of choice for patients presenting with traumatic
thoracic aortic ruptures.Restenosis after carotid endarterectomy in a multicenter regional
registry
Philip P. Goodney, Brian W. Nolan, Jens Eldrup-Jorgensen, Donald S. Likosky,
Jack L. Cronenwett, for the Vascular Study Group of Northern New England
Background: Level I evidence shows conventional carotid endarterectomy
(CEA) with patch angioplasty results in lower rates of restenosis. However,
whether this information has affected practice patterns and outcomes in
real-world vascular surgery settings is unclear.
Methods: Within the Vascular Study Group of New England (VSGNE), we
studied 2981 patients undergoing 2981 first-time CEAs between January 1,
2003, and June 31, 2008. Rates of restenosis (defined by duplex ultrasound
imaging at the 1-year follow-up) were estimated using life-table analysis.
Cox proportional hazards models were used to identify multivariable predic-
tors of postoperative restenosis 1 year.
Results: Across 58 surgeons and 11 hospitals, we studied 2611 conventional
CEAs (88% of all CEAs) and 370 eversion CEAs (12% of all CEAs). Median
follow-up was 12.8 months (range, 1-35 months). The proportion of conven-
tional CEAs performed with patching increased from 87% to 96% (P < .001)
between 2003 and 2008, whereas eversion CEA declined from 18% to 5% (P< .001). Restenosis occurred in 303 patients (10%); by life-table analysis,
the restenosis rate at 1 year was 6.2% (95% confidence interval [CI], 4.7%-
6.8%). Restenoses were most commonly noncritical: 50%-79% restenosis in
7.9%, 80%-99% restenosis in 1.7%, and occlusion in 0.5%. Univariate analyses
showed significant differences in 80% to 100% restenosis by procedure type
(2% in conventional CEA, 6% in eversion CEA, P < .002), the year of procedure
(3.2% in 2003, 0% in 2008; P < .03), and use of patching in conventional CEA
(2.9% no patch, 1% with patch; P < .008). By multivariable analysis, absence
of patching (hazard ratio [HR], 3.2; 95% CI, 1.5-7.0), contralateral internal
carotid artery stenosis >80% (HR, 4.1; 95% CI, 1.4-11.5), and dialysis depen-
dence (HR, 3.5; 95% CI, 1.2-9.8) were independently associated with a higher
risk of an 80% to 100% restenosis. Of the 51 patients with 80% to 99% resteno-
sis, 14 underwent reintervention 1 year, comprising 4 reoperations and 10
carotid artery stent procedures. Of the 15 patients with a carotid occlusion
1 year, transient ischemic attacks occurred in 2 and a disabling stroke in 1.
Conclusions: In our region, restenosis after CEA, especially clinically signif-
icant restenosis 1 year after surgery, decreased slightly over time. This
improvement in outcome was associated with several factors, including an
increase in patching after conventional CEA, a process of care that was
studied and encouraged within our vascular study group. These results high-
light the utility of regional quality-improvement efforts in improving
outcomes in vascular surgery.Outcomes of carotid stenting compared with endarterectomy are
equivalent in asymptomatic patients and inferior in symptomatic patients
Jeannine K. Giacovelli, Natalia Egorova, Rajeev Dayal, Annetine Gelijns,
James McKinsey, K. Craig Kent
Background: Despite the current Centers for Medicare and Medicaid
Services coverage criteria for carotid artery stenting (CAS), consensus
regarding its appropriateness in patients with carotid artery stenosis has
not been reached. This is one of the first population-based studies to use
a dedicated administrative convention for the endovascular procedure to
address whether there is a cohort of patients in whom CAS is more beneficial
than carotid endarterectomy (CEA).
Methods: We analyzed in-hospital mortality, postoperative stroke, and
combined postoperative stoke/mortality in 47,752 CAS or CEA hospitaliza-
tions, matched by propensity score, in discharge data sets obtained from
the states of New York and California for the years 2005 to 2007. Other
outcomes included postoperative complications, length of stay, and
volume-outcome relationships.
Results: For symptomatic patients undergoing CAS, rates were significantly
higher for in-hospital mortality (3.7% vs 1.3%) and combined stroke/
mortality (8.3% vs 4.6%) compared with CEA. For asymptomatic patients,
there was no statistical difference between mortality (0.6% vs 0.4%), stroke
(2.0% vs 1.8%), or combined stroke/mortality (2.4% vs 1.9%) across the endo-
vascular and open procedures, respectively. Postoperative respiratory and
urinary complications as well as cranial neuropathy were more common
after CEA, whereas postoperative complications, including device malfunc-
tion and hypotension, were more frequent after CAS. We did not find
a volume-outcome relationship for CEA, but one did exist for CAS.
Conclusions: In symptomatic patients with carotid artery stenosis, the most
appropriate procedure appears to be CEA, whereas CAS appears to be a suit-
able minimally invasive approach for asymptomatic patients. On the basis of
these results and data from recent multicenter randomized trials, the use of
CAS in symptomatic patients should be approached with caution.Accuracy of duplex sonography scans after renal artery stenting
Shawn H. Fleming, Ross P. Davis, Timothy E. Craven, Joel K. Deonanan,
Christopher J. Godshall, Kimberley J. Hansen
Purpose: Reports of duplex sonography scan criteria for recurrent renal
arterial (RA) stenosis after endoluminal stenting have suggested that criteria
for native arteries may overestimate recurrent disease. This retrospective
report examines the utility of renal duplex sonography (RDS) scans to define
the presence of significant (ie, 60%) renovascular disease (RVD) after
percutaneous angioplasty and endoluminal stenting (PTAS).
Methods: Demographic, duplex, and angiographic data were reviewed and
compared. RDS was obtained. Peak systolic velocities (PSV) were obtained
Abstracts 545after PTAS from multiple sites along the main RA from both anterior and
flank approaches. Comparable images from digital subtraction angiography
were independently examined for restenosis. Percent diameter stenosis
was determined from the site of maximal stenosis compared with the normal
RA distal to the stent. Sensitivity and specificity were estimated and 95%
confidence intervals (CIs) were computed after adjusting for within patient
‘‘clustering’’ of observations applying native RA RDS criteria using angiog-
raphy as the gold standard. Receiver operating characteristic (ROC) curves
were used to estimate the optimal RDS values for recurrent stenosis.
Results: From October 2003 to June 2009, 49 patients had angiographic
imaging after PTAS. There were 30 patients (18 women, 12 men; mean
age, 71  9 years) provided technically adequate paired angiographic and
RDS assessment after PTAS for 66 RAs. Paired analysis was performed for
23 RAs after primary PTAS and 43 RAs after secondary treatment. The prev-
alence of significant restenosis was 35% (23 of 66 RAs). RAs with greater than
60% diameter restenosis had higher peak systolic velocity (PSV) compared to
those without (2.48  1.15 millisecond vs 1.44  0.58 millisecond; P < .001).
Compared to angiography, RA-PSV 1.8 millisecond with distal RA turbu-
lence demonstrated a sensitivity of 73% (95% CI, 54%, 91%), specificity of
80% (95% CI, 67%, 93%), and an overall accuracy of 77% (95% CI, 67%, 88%)
with a positive predictive value of 64% (95% CI, 46%, 82%). Optimal RDS value
estimated by ROC curve resulted in RA-PSV of 2.5 millisecond which was
associated with a sensitivity of 59% (95% CI, 36%, 82%), specificity of 95%
(95% CI, 89%, 100%), an accuracy of 83% (95% CI, 74%, 92%), and a positive
predictive value of 87% (95% CI, 68%, 100%).
Conclusion: Renal duplex sonography has utility to detect significant rest-
enosis after PTAS. RDS criteria for significant native RA stenosis compare
favorably with optimal RDS criteria for restenosis estimated by ROC
curves.Endovascular and open surgery for acute occlusion of the superior
mesenteric artery
Tomas A. Block, Stefan Acosta, Martin Bjo¨rck
Background: Acute thromboembolic occlusion of the superior mesenteric
artery (SMA) is associated with high mortality. Recent advances in diagnos-
tics and surgical techniques may affect outcome.
Methods: Through the Swedish Vascular Registry (Swedvasc), 121 open and
42 endovascular revascularizations of the SMA at 28 hospitals during 1999
to 2006 were identified. Patient medical records were retrieved, and
survival was analyzed with multivariate Cox-regression analysis.
Results: The number of revascularizations of the SMA increased over time
with 41 operations in 2006, compared to 10 in 1999. Endovascular approach
increased sixfold by 2006 as compared to 1999. The endovascular group had
thrombotic occlusion (P < .001) and history of abdominal angina (P = .042)
more often, the open group had atrial fibrillation more frequently (P =
.031). All the patients in the endovascular group, but only 34% after open
surgery, underwent completion control of the vascular reconstruction (P <
.001). Bowel resection (P < .001) and short bowel syndrome (SBS; P =
.009) occurred more frequently in the open group. SBS (hazard ratio [HR],
2.6; 95% confidence interval [CI], 1.3-5.0) and age (HR, 1.03/year; 95% CI,
1.00-1.06) were independently associated with increased long-term
mortality. Thirty-day and 1-year mortality rates were 42% vs 28% (P = .03)
and 58% vs 39% (P = .02), for open and endovascular surgery, respectively.
Long-term survival after endovascular treatment was better than after open
surgery (log-rank, P = .02).
Conclusion: The results after endovascular and open surgical revasculariza-
tion of acute SMA occlusion were favorable, in particular among the endo-
vascularly treated patients. Group differences need to be confirmed in
a randomized trial.
